JP2022546594A5 - - Google Patents

Info

Publication number
JP2022546594A5
JP2022546594A5 JP2022514704A JP2022514704A JP2022546594A5 JP 2022546594 A5 JP2022546594 A5 JP 2022546594A5 JP 2022514704 A JP2022514704 A JP 2022514704A JP 2022514704 A JP2022514704 A JP 2022514704A JP 2022546594 A5 JP2022546594 A5 JP 2022546594A5
Authority
JP
Japan
Application number
JP2022514704A
Other languages
Japanese (ja)
Other versions
JP2022546594A (ja
JPWO2021046442A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049534 external-priority patent/WO2021046442A1/en
Publication of JP2022546594A publication Critical patent/JP2022546594A/ja
Publication of JP2022546594A5 publication Critical patent/JP2022546594A5/ja
Publication of JPWO2021046442A5 publication Critical patent/JPWO2021046442A5/ja
Pending legal-status Critical Current

Links

JP2022514704A 2019-09-05 2020-09-04 新規crispr dnaターゲティング酵素及びシステム Pending JP2022546594A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962896308P 2019-09-05 2019-09-05
US62/896,308 2019-09-05
PCT/US2020/049534 WO2021046442A1 (en) 2019-09-05 2020-09-04 Novel crispr dna targeting enzymes and systems

Publications (3)

Publication Number Publication Date
JP2022546594A JP2022546594A (ja) 2022-11-04
JP2022546594A5 true JP2022546594A5 (https=) 2023-09-11
JPWO2021046442A5 JPWO2021046442A5 (https=) 2023-09-11

Family

ID=74852250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514704A Pending JP2022546594A (ja) 2019-09-05 2020-09-04 新規crispr dnaターゲティング酵素及びシステム

Country Status (7)

Country Link
US (1) US20220282283A1 (https=)
EP (1) EP4025588A4 (https=)
JP (1) JP2022546594A (https=)
CN (1) CN114341166A (https=)
AU (1) AU2020341711A1 (https=)
CA (1) CA3153005A1 (https=)
WO (1) WO2021046442A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL308806A (en) 2021-06-01 2024-01-01 Arbor Biotechnologies Inc Gene editing systems including nuclease crisper and their uses
US12131057B2 (en) * 2022-01-28 2024-10-29 Western Digital Technologies, Inc. Encoding and integrity markers for molecular storage applications
CN119546757A (zh) 2022-05-25 2025-02-28 宏基因组学公司 肝酶表达的补充
WO2024173645A1 (en) 2023-02-15 2024-08-22 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2024187140A2 (en) * 2023-03-08 2024-09-12 Metagenomi, Inc. Class 2, type v crispr systems
CN118773168B (zh) * 2023-11-24 2025-07-25 华智生物技术有限公司 CRISPR/Cas效应蛋白HT001及系统与应用
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4159856A1 (en) * 2015-06-18 2023-04-05 The Broad Institute, Inc. Novel crispr enzymes and systems
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2016205759A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
CN109153980B (zh) * 2015-10-22 2023-04-14 布罗德研究所有限公司 Vi-b型crispr酶和系统
JP7109784B2 (ja) * 2015-10-23 2022-08-01 プレジデント アンド フェローズ オブ ハーバード カレッジ 遺伝子編集のための進化したCas9蛋白質
EP3445358B1 (en) * 2016-04-19 2023-11-15 Keto Patent Group, Inc. Administration of dihydroberberine
WO2018035388A1 (en) * 2016-08-17 2018-02-22 The Broad Institute, Inc. Novel crispr enzymes and systems
US11168322B2 (en) * 2017-06-30 2021-11-09 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof
US11713452B2 (en) * 2017-09-08 2023-08-01 University Of North Texas Health Science Center Engineered CAS9 variants
AU2020291467A1 (en) * 2019-06-14 2021-12-23 Arbor Biotechnologies, Inc. Novel crispr DNA targeting enzymes and systems

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022546594A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)